The global sperm count test market was valued at USD 362.39 million in 2025 and is expected to grow steadily to reach USD 559.89 million by 2033, registering a CAGR of 5.65% during the forecast period from 2026 to 2033. This upward trajectory reflects a combination of medical, social, and technological factors that are reshaping reproductive healthcare. One of the primary contributors to this growth is the increasing prevalence of male infertility, which has prompted a stronger focus on diagnostic tools and early-stage fertility evaluation. Alongside this, rising awareness regarding reproductive health among men and couples has encouraged proactive testing, further supporting market expansion.

Market Size & Forecast

• 2025 Market Size: USD 362.39 Million
• 2033 Projected Market Size: USD 559.89 Million
• CAGR (2026-2033): 5.65%
• North America: Largest market in 2025
• Asia Pacific: Fastest growing market
• Sperm Count Test market size and growth forecast (2023-2033)

Key Market Trends & Insights

• North America market dominated the global market in 2025 and accounted for the largest revenue share of 36.14%
• The dominance of North America can be attributed to advanced healthcare infrastructure, high awareness levels, and widespread availability of fertility services. The region benefits from strong research and development capabilities, along with a higher adoption rate of technologically advanced diagnostic tools. Additionally, favorable insurance coverage and increasing acceptance of fertility treatments contribute to sustained market leadership.
• S. market is anticipated to register the fastest growth rate during the forecast period.
• The United States is expected to witness rapid growth due to increasing infertility rates, greater awareness campaigns, and continuous innovation in diagnostic technologies. The presence of leading market players and ongoing investments in reproductive health research further support market expansion. Rising demand for home-based fertility testing solutions also contributes to accelerated growth in this region.
• In terms of product segment, the clinical semen analyzer systems (CASA / automated analyzers) segment held the largest revenue share in 2025.

Clinical semen analyzer systems dominate the market due to their high accuracy, efficiency, and ability to provide detailed sperm analysis. These automated systems reduce human error and improve diagnostic reliability, making them a preferred choice in clinical settings. Their integration with digital platforms and data analytics tools enhances their utility, further driving adoption among healthcare providers.

Download a free sample copy of the Sperm Count Test market report to understand detailed coverage and inclusions in the final report

In recent years, changing societal patterns such as delayed parenthood have significantly influenced demand for fertility diagnostics. Many individuals and couples are choosing to have children later in life, often encountering fertility challenges that require clinical intervention. This has led to increased reliance on sperm count tests as an initial diagnostic step. Additionally, the growing availability of fertility clinics across both developed and emerging regions has made such services more accessible. Government-backed initiatives aimed at improving reproductive health awareness, combined with higher healthcare expenditure, have also strengthened the adoption of fertility testing solutions globally.

A major factor driving the market is the rising incidence of male infertility linked to modern lifestyle patterns. Sedentary routines, poor dietary habits, stress, and exposure to harmful substances have contributed to declining sperm quality and count. Research indicates that infertility affects approximately 15% of couples worldwide, with male factors accounting for nearly half of these cases. In the United States alone, about 9% of men of reproductive age experience fertility-related challenges, highlighting the widespread nature of the issue.

Lifestyle-related risks continue to play a critical role in shaping demand for sperm count tests. Obesity, for example, is associated with reduced testosterone levels and compromised sperm quality. Similarly, smoking and excessive alcohol consumption are known to cause DNA damage in sperm, leading to reduced motility and count. In India, tobacco use remains a significant concern, with approximately 200.2 million men aged 15 and above reported as tobacco users in 2022. These patterns have encouraged individuals to adopt preventive health measures, including routine fertility monitoring through both clinical and at-home testing solutions.

Looking for more specific insights? Customize this report to suite your business needs

Environmental factors further compound the issue of declining male fertility. Increased exposure to pollutants such as pesticides, industrial chemicals, and heavy metals has been strongly linked to reproductive health deterioration. As industrialization and urbanization expand, these environmental risks are becoming more prevalent, resulting in a higher incidence of fertility-related concerns. Consequently, there is a growing emphasis on early diagnosis and regular monitoring, which is driving demand for sperm count testing technologies in both healthcare facilities and home settings.

The competitive landscape of the sperm count test market is highly fragmented, characterized by the presence of numerous regional and international players. Companies are actively pursuing strategies such as partnerships, collaborations, mergers, acquisitions, and product innovations to strengthen their market position. Technological advancements, particularly in automated semen analysis systems and user-friendly home testing kits, are enabling companies to differentiate their offerings and capture a larger share of the market.

Explore Grand View Horizon to see global and regional level statistics related to the Sperm Count Test Market

Conclusion

The sperm count test market is evolving in response to a complex interplay of medical, lifestyle, and environmental factors. Increasing infertility rates, particularly among men, have brought reproductive health into sharper focus, encouraging early diagnosis and routine monitoring. Technological advancements in diagnostic tools, combined with greater accessibility to fertility services, are transforming how individuals approach fertility assessment. Regional dynamics, particularly the dominance of North America and the rapid growth of Asia Pacific, highlight the global nature of this market’s expansion. As awareness continues to rise and healthcare systems adapt to changing reproductive trends, the demand for accurate, efficient, and accessible sperm count testing solutions is expected to remain strong, supporting sustained market growth in the years ahead.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare